No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / genetics
-
Carcinoma, Non-Small-Cell Lung / mortality
-
Carcinoma, Non-Small-Cell Lung / secondary
-
Carcinoma, Non-Small-Cell Lung / surgery*
-
Disease-Free Survival
-
ErbB Receptors / genetics
-
Female
-
Gefitinib
-
Humans
-
Japan
-
Kaplan-Meier Estimate
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / mortality
-
Lung Neoplasms / pathology
-
Lung Neoplasms / surgery*
-
Male
-
Middle Aged
-
Mutation
-
Neoplasm Recurrence, Local / surgery
-
Neoplasm Staging
-
Neoplasm, Residual / surgery
-
Pneumonectomy* / adverse effects
-
Pneumonectomy* / mortality
-
Protein Kinase Inhibitors / therapeutic use*
-
Quinazolines / therapeutic use*
-
Salvage Therapy
-
Time Factors
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Quinazolines
-
EGFR protein, human
-
ErbB Receptors
-
Gefitinib